Who has invested in Cybrexa Therapeutics?

HighCape Capital, Elm Street Ventures are named among the investors backing Cybrexa Therapeutics.

Cybrexa Therapeutics Funding: $6M Raised, Series B (2021)

Cybrexa Therapeutics funding overview

Cybrexa Therapeutics is based in New Haven. Cybrexa Therapeutics has raised $6M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in March 2021. The round record for Cybrexa Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include HighCape Capital, Elm Street Ventures. 2 distinct backers are named across the disclosed rounds.

Cybrexa Therapeutics at a glance

Total raised: $6M
Latest round: Series B
Latest round date: March 2021
Headquarters: New Haven
Notable investors: HighCape Capital, Elm Street Ventures

Frequently asked about Cybrexa Therapeutics funding

How much has Cybrexa Therapeutics raised?: Cybrexa Therapeutics has raised $6M in total disclosed funding across the rounds on record.
Who has invested in Cybrexa Therapeutics?: HighCape Capital, Elm Street Ventures are named among the investors backing Cybrexa Therapeutics.
What was the latest Cybrexa Therapeutics funding round?: The most recent disclosed round is a Series B, announced in March 2021.
Where is Cybrexa Therapeutics based?: Cybrexa Therapeutics is based in New Haven.
When did Cybrexa Therapeutics last raise?: The last disclosed Cybrexa Therapeutics round closed in March 2021 at Series B.

Every Cybrexa Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in New Haven at a similar stage.

Cybrexa Therapeutics Funding: $6M Raised, Series B (2021)

Cybrexa Therapeutics funding overview

Cybrexa Therapeutics at a glance

Frequently asked about Cybrexa Therapeutics funding

Companies related to Cybrexa Therapeutics (40)

Browse related funding lists (3)